Jason Gale

Melbourne

Senior Editor and Biosecurity Correspondent at Bloomberg News

Senior editor @business with a special interest in medical science, biosecurity & global health

Featured in: Favicon

bloomberg.com Favicon

uol.com.br (+2) Favicon

msn.com

globo.com (+1) Favicon

elpais.com Favicon

indiatimes.com Favicon

washingtonpost.com Favicon

time.com

yahoo.com (+7) Favicon

hindustantimes.com + 87 more

Articles

Tariffs Have Stifled Trade, Yet Measles Is Spreading With Few Limits

1 week ago | bloomberg.com | Jason Gale

Hi, it’s Jason in Melbourne. While world trade is being stifled by tariffs and threats of tariffs, measles — regrettably — is one export that seems to be booming. But first…Last week, Taiwan reported three new cases, including two imported from Vietnam, where about 90,000 infections have occurred over the past year.
IVF Pioneer Monash Slumps 30% After News of Baby Born From Embryo Mix-Up

1 week ago | bloomberg.com | Jason Gale

Despite the gravity of the case, the company said it doesn’t currently expect a material impact on 2025 earnings and has notified its insurers. Photographer: Jasper Juinen/Bloomberg(Bloomberg) -- Monash IVF Group Ltd. plunged a record 36% on Friday after the reproductive health-care company said that an embryo belonging to one patient was mistakenly implanted into another, resulting in the birth of a child.
Once-rare fungal diseases are killing millions in an unprepared world

3 weeks ago | japantimes.co.jp | Jason Gale

When most people think of dangerous infections, they picture bacteria or viruses. But for infectious disease specialists like Peter Chin-Hong, one of the most insidious threats lurking in hospitals and clinics today is fungal.
Once-Rare Invasive Fungal Diseases Now Kill Millions Each Year

3 weeks ago | news.bloombergtax.com | Jason Gale

When most people think of dangerous infections, they picture bacteria or viruses. But for infectious disease specialists like Peter Chin-Hong, one of the most insidious threats lurking in hospitals and clinics today is fungal.
Once-Rare Fungal Diseases Are Killing Millions in an Unprepared World

3 weeks ago | bloomberg.com | Jason Gale

Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world For Customers Bloomberg Anywhere Remote Login Software Updates Manage Products and Account Information Support Americas+1 212 318 2000 EMEA+44 20 7330 7500 Asia Pacific+65 6212 1000 Company About Careers Inclusion at Bloomberg Tech at Bloomberg Philanthropy Sustainability Bloomberg London...
Once-Rare Invasive Fungal Diseases Now Kill Millions Each Year

3 weeks ago | news.bloomberglaw.com | Jason Gale

When most people think of dangerous infections, they picture bacteria or viruses. But for infectious disease specialists like Peter Chin-Hong, one of the most insidious threats lurking in hospitals and clinics today is fungal.
Fruits of Decades of AIDS Vaccine Research Imperiled by Trump’s Withdrawal of US Funding

3 weeks ago | yahoo.com | Jason Gale |Ashleigh Furlong |Janice Kew

(Bloomberg) -- After decades of failed attempts, scientists were optimistic that a new generation of HIV vaccine candidates would finally succeed — changing the course of a pandemic that’s claimed more than 42 million lives since 1981. But that hope is now dimming as the US moves to pull vital funding. Most Read from BloombergAdvertisementA leaked document detailing the fate of more than 6,200 USAID programs lists two leading HIV vaccine efforts among 5,341 projects earmarked for termination.
Fruits of Decades of AIDS Vaccine Research Imperiled by Trump’s Withdrawal of US Funding

3 weeks ago | bloomberg.com | Jason Gale |Ashleigh Furlong |Janice Kew

After decades of failed attempts, scientists were optimistic that a new generation of HIV vaccine candidates would finally succeed — changing the course of a pandemic that’s claimed more than 42 million lives since 1981. But that hope is now dimming as the US moves to pull vital funding. A leaked document detailing the fate of more than 6,200 USAID programs lists two leading HIV vaccine efforts among 5,341 projects earmarked for termination.
How Did Measles Make a Comeback in the US?: QuickTake

4 weeks ago | news.bloomberglaw.com | Jessica Nix |Jason Gale

Thanks to the introduction of a vaccine in 1963, measles was considered eliminated in the US in 2000. Yet the highly contagious disease has reemerged as a threat in 2025 as declining vaccination rates fuel outbreaks around the country. A total of 378 confirmed measles cases had been reported by 18 states or cities as of March 20, a toll that has last year’s. In Texas, an on Feb. 26 in the first reported US death from the disease in a decade.
Measles Was Eradicated in the US. How Did It Make a Comeback?

4 weeks ago | bloomberg.com | Jessica Nix |Jason Gale

Vials of measles, mumps and rubella vaccine.Photographer: Justin Sullivan/Getty ImagesHow easy or hard was it to use Bloomberg.com today? Share feedbackHave a confidential tip for our reporters? Get in TouchBefore it’s here, it’s on the Bloomberg Terminal LEARN MOREThanks to the introduction of a vaccine in 1963, measles was considered eliminated in the US in 2000. Yet the highly contagious disease has reemerged as a threat in 2025 as declining vaccination rates fuel outbreaks around the country.